Showing 3731-3740 of 4063 results for "".
- VSY Biotechnology Says It Has Developed a New Drug to Treat COVID-19https://modernod.com/news/vsy-biotechnology-says-it-has-developed-a-new-drug-to-treat-covid-19/2477774/Ophthalmic company VSY Biotechnology announced that its research center has developed a new drug, TR-C 19, to treat COVID-19. Studies have shown that TR-C 19 can neutralize the virus isolated under laboratory conditions, according to a company news release. The drug is now at the authority
- Report: More Than Half of All Age-Related Macular Degeneration Cases Go Undiagnosedhttps://modernod.com/news/report-more-than-half-of-all-age-related-macular-degeneration-cases-go-undiagnosed/2477776/In the nine major pharmaceutical markets, less than half of age-related macular degeneration (AMD) cases were diagnosed in 2019 in adults aged 50 years and older, according to analytics company GlobalData. The company’s latest report, ‘
- Artificial Intelligence Algorithm Can Rapidly Detect Severity of Common Blinding Eye Diseasehttps://modernod.com/news/artificial-intelligence-algorithm-can-rapidly-detect-severity-of-common-blinding-eye-disease/2477752/A new artificial intelligence (AI) algorithm developed by researchers at New York Eye and Ear Infirmary of Mount Sinai (NYEE) can rapidly and accurately detect age-related macular degeneration (AMD), according to a company news release. The study, published in the April/May issue of Tr
- Alcon to Highlight Scientific Program Showcasing Latest Innovations at Virtual ASCRShttps://modernod.com/news/alcon-to-highlight-scientific-program-showcasing-latest-innovations-at-virtual-ascrs/2477746/Alcon will present data that supports advancements in cataract surgery during the virtual American Society of Cataract and Refractive Surgery (ASCRS) 2020 annual meeting, taking place May 16-17. The company will also host a virtual exhibit booth that will provide information on its latest product
- US Physician Survey Illustrates the Impact of Thyroid Eye Disease on Patient Quality of Lifehttps://modernod.com/news/us-physician-survey-illustrates-the-impact-of-thyroid-eye-disease-on-patient-quality-of-life/2477745/Horizon Therapeutics announced results of a US physician survey showing that endocrinologists and ophthalmologists perceive thyroid eye disease (TED) to have a significant burden on their patients’ quality of life. The analysis was accepted as a poster presentation at the AACE 29th Ann
- VisionCare Announces CE Mark Approval of the Tsert-SI Delivery System for the CentraSight Treatment Programhttps://modernod.com/news/visioncare-announces-ce-mark-approval-of-the-tsert-si-delivery-system-for-the-centrasight-treatment-program/2477744/VisionCare has received CE Mark for the Tsert-SI delivery system for the CentraSight treatment program, which includes the Implantable Miniature Telescope (by Dr. Isaac Lipshitz). The Tsert-SI delivery system includes a pre-loaded telescope implant injector, which only requires a 6.5mm incision,
- Mystery Inflammatory Syndrome In Kids And Teens Likely Linked To COVID-19https://modernod.com/news/mystery-inflammatory-syndrome-in-kids-and-teens-likely-linked-to-covid-19/2477722/Sixty-four children and teens in New York State are suspected of having a mysterious inflammatory syndrome that is believed to be linked to COVID-19, the New York Department of Health said in an alert issued Wednesday, as
- Lineage Cell Therapeutics Reports New Data With OpRegen for the Treatment of Dry AMD With Geographic Atrophyhttps://modernod.com/news/lineage-cell-therapeutics-reports-new-data-with-opregen-for-the-treatment-of-dry-amd-with-geographic-atrophy/2477713/Lineage Cell Therapeutics announced that updated results from a phase 1/2a study of its lead product candidate OpRegen, a retinal pigment epithelium (RPE) cell transplant therapy currently in development for the treatment of dry age-related macular degeneration (AMD), were published online via th
- Market Scope: New Refractive Atlas Identifies Location of LVC Candidates and Refractive Surgeonshttps://modernod.com/news/market-scope-new-refractive-atlas-identifies-location-of-lvc-candidates-and-refractive-surgeons/2477682/The metro areas of New York, Los Angeles, Dallas, and Chicago account for 14 percent of the population age 20 to 44 in the US and 9.3 percent of the US population with refractive error, according to a Market Scope report. However, on a per capita share basis, most of the metro areas in Col
- BVI Names David Murray as Chief Financial Officerhttps://modernod.com/news/bvi-names-david-murray-as-chief-financial-officer/2477662/BVI announced that it has named David Murray as Chief Financial Officer. Most recently, Mr. Murray served as Chief Financial Officer of Alcon from 2015 until its $30bn spin-off from Novartis Group AG in 20